Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 22.25 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.45 | -1.98% | 22.25 | 22.77 | 21.78 | 22.70 | 22.70 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 20.10 | 24.99 | 4.89 | 19.57% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,202 | 1,215,471 | $ 22.20 | $ 26,988,454 | 1,321,542 | 8.26 - 29.675 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:41:13 | 1 | $ 22.25 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.81B | 126.19M | $ -123.58M | -1.27 | - | 105.17M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 23.55 | 24.10 | 21.78 | 23.47 | 934,175 | -1.30 | -5.52% |
| 1 Month | 28.96 | 28.96 | 21.78 | 25.36 | 1,275,562 | -6.71 | -23.17% |
| 3 Months | 21.30 | 29.675 | 20.24 | 24.74 | 1,322,911 | 0.95 | 4.46% |
| 6 Months | 25.94 | 29.675 | 17.67 | 22.58 | 1,273,637 | -3.69 | -14.23% |
| 1 Year | 8.43 | 29.675 | 8.26 | 18.97 | 1,385,389 | 13.82 | 163.94% |
| 3 Years | 7.20 | 29.675 | 4.45 | 15.02 | 997,554 | 15.05 | 209.03% |
| 5 Years | 8.57 | 29.675 | 4.24 | 13.67 | 766,366 | 13.68 | 159.63% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient. |
